Janus Kinase Inhibitor Tofacitinib Shows Potent Efficacy in a Mouse Model of Autoimmune Lymphoproliferative Syndrome (ALPS)
Crossref DOI link: https://doi.org/10.1007/s10875-015-0203-z
Published Online: 2015-10-09
Published Print: 2015-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yokoyama, Seiji
Perera, Pin-Yu
Terawaki, Seigo
Watanabe, Nobumasa
Kaminuma, Osamu
Waldmann, Thomas A.
Hiroi, Takachika
Perera, Liyanage P.
Text and Data Mining valid from 2015-10-01